News
MRK
121.41
+1.82%
2.17
The top-performing pharma and biotech stocks as group sees resurgence
Seeking Alpha · 11h ago
Midday Fly By: Coinbase, Pinterest report lower-than-expected Q4 results
TipRanks · 13h ago
Caterpillar, Nike share gains contribute to Dow's nearly 250-point jump
MarketWatch · 13h ago
RFK Jr. HHS shakeup continues as deputy secretary leaving post - report
Seeking Alpha · 13h ago
Dow's nearly 125-point rally led by gains for Salesforce, Caterpillar stocks
MarketWatch · 14h ago
Dow Movers: GS, MRK
NASDAQ · 14h ago
Did Eli Lilly Just Make a Deal for Its Next Blockbuster Drug?
The Motley Fool · 14h ago
Is Merck (MRK) a Buy as Wall Street Analysts Look Optimistic?
NASDAQ · 15h ago
Merck upgraded to Buy from Hold at Deutsche Bank
TipRanks · 16h ago
Merck’s New Ovarian Cancer Win And Women’s Health Push Tested By Valuation
Simply Wall St · 18h ago
Have Merck Insiders Been Selling Stock?
Simply Wall St · 18h ago
Top Merck Executive Makes Bold Move With Major Stock Sale
TipRanks · 1d ago
AbbVie files lawsuit over selection of Botox for Medicare price negotiations
Seeking Alpha · 1d ago
VONE, UNH, MRK, TMO: ETF Outflow Alert
NASDAQ · 1d ago
Merck: Keytruda Remains Resilient Despite LOE Risks - Buy Upon Correction
Seeking Alpha · 1d ago
Organon falls as women’s health unit drives Q4 miss
Seeking Alpha · 1d ago
Merck To Present Data Across Multiple Genitourinary Cancers From Several Approved And Investigational Medicines At 2026 ASCO GU Cancers Symposium
Benzinga · 1d ago
Merck Advances Treatment of Bladder and Kidney Cancers with New Data at 2026 ASCO GU Cancers Symposium
Barchart · 2d ago
Is Merck (MRK) Still Attractively Priced After Strong Five Year Share Price Performance
Simply Wall St · 2d ago
Moderna: FDA RTF Derails mRNA-1010 And Reignites The Sell Case
Seeking Alpha · 2d ago
More
Webull provides a variety of real-time MRK stock news. You can receive the latest news about Merck & Co through multiple platforms. This information may help you make smarter investment decisions.
About MRK
Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. It sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.